Tag: Astrazeneca Ovarian Cancer Drug
Astrazeneca ovarian cancer drug Lynparza shown to improve survival chances
Pharma giant AstraZeneca has reported that its ovarian cancer drug Lynparza (olaparib) as a maintenance therapy has considerably improved the survival chances of patients with ... Read More